feed,title,long_url,short_url
Benzinga,Seagen's Tukysa Becomes First FDA-Approved Treatment For HER2-Positive Metastatic Colorectal Cancer,https://benzinga.com/general/biotech/23/01/30497653/seagens-tukysa-becomes-first-fda-approved-treatment-for-her2-positive-metastatic-colorectal-cance,https://da.gd/JVKi
